Complex KMT2A Rearrangement in AML with Optical Genome Mapping

 
CASE REPORT: the use of optical genome mapping
(
Bionano
)
to understand a complex mechanism of a 
KMT2A
rearrangement
 in an 
AML 
case.
 
Catherine Menten and Barbara Dewaele
Cytogenetic lab, human genetic, CHU Liège, Belgium
 
Céline Lété
1
, Geneviève Ameye², Pablo Beckers
1
, Lucienne Michaux², Vincent Bours,
Mauricette Jamar
1
, Jolien De Bie², Barbara Dewaele², Catherine Menten
1
1
Human genetics, CHU Liège, Belgium
²Center for Human Genetics , UZ Leuven, Belgium
 
Content
 
2
 
Catherine Menten and Barbara Dewaele
Cytogenetic lab, human genetic, CHU Liège, Belgium
 
Standard karyotype shows a translocation 
t(10;11)(p12;q23) 
in seventeen mitoses. 
KMT2A
rearrangement
 
 
was confirmed by FISH analysis using a gene specific break apart probe.
However, the observation of informative metaphases shows that the 
KMT2A 
rearrangement
is located 
on the short arm of  a derivative chromosome 10
.
 
A
 : standard karyotype Q-banding :
46,XX,t(10;11)(p12;q23)
B
 : specific KMTA FISH (break apart probe,
Vysis)
 
Introduction
 
:
 the diagnosis of 
AML M5 
(FAB classification) was established after cytology and
cytometry analysis in an eighty-six year old woman with 
46% myeloblasts 
in the bone marrow.
 
3
 
Aim
 
: 
MLLT10 
fusion
 is known to result from an 
inversion
 which can occur either 
before or after
the t(10;11)
 translocation. An 
RT-PCR Hemavision
 test would have been informative, but was 
not
possible
 due to the lack of RNA. 
Optical genome mapping (OGM) 
is a new, “all in one”, technique
allowing the genome-wide detailed characterization of most structural rearrangements (balanced
or not) .
 
Catherine Menten and Barbara Dewaele
Cytogenetic lab, human genetic, CHU Liège, Belgium
 
Results :
1.
 
Ultra long DNA fragments (
>150kb
)
extracted from bone marrow  were
labeled then linearised using 
Saphyr
(Bionano Genomics)
.
Then, the pattern was compared with
reference genome via OGM technique,
showing pseudodiploïd karyotype
with complex aberrations involving a
MLLT10-KMT2A rearrangement.
 
Chromosome 
10
 (
right
) and 
11
 (
left
) ( 
Bionano Access 
(Genome build GRCh37/hg19)) after bio-
computing analyses using « 
De Novo Assembly 
» (coverage 150x), « 
Rare variant 
» (coverage
300x) and « 
Copy Number Analysis 
» (coverage 300x) pipelines .
 
4
 
Catherine Menten and Barbara Dewaele
Cytogenetic lab, human genetic, CHU Liège, Belgium
 
Results : 
2
. 
After independent analyses, we observed 
two inversions 
inside the long arm of one
chromosome 
11
 and 
two translocations 
between the short arm of one chromosome 
10
 and the
long arm of chromosome 
11
 which ultimately lead to the fusion of the genes 
KMT2A
 and 
MLLT10
.
 
A : 
t(10;11)(p12.31;q23.3)(21912195;118349783)
B
 
:
 
t(10;11)(p12.31;q13.4)(21861988;73345254)
 
C : 
inv(11)(q14.2q23.3)(86854533_118364657inv)
D : 
inv(11)(q13.4q14.2)(73340798_86847507inv)
 
Conclusion : 
OGM technique 
allowed us 
to observe a 
KMT2A-
MLLT10
 fusion resulting from 
several anomalies involving
chromosome 10 and 11
:
 
ogm\[GRCh37\]
t(10;11)(p12.31;q13.4)(21861988;73345254), [
MLLT10-PLEKHB1
]
t(10;11)(p12.31;q23.3)(21912195;118349783), [
MLLT10-KMT2A
]
inv(11)(q13.4q14.2)(73340798_86847507inv),
inv(11)(q14.2q23.3)(86854533_118364657inv)
 
We conclude that the analysis of this AML case nicely
illustrates the value of OGM to resolve complex aberrations
using only one assay.
 
5
 
Catherine Menten and Barbara Dewaele
Cytogenetic lab, human genetic, CHU Liège, Belgium
Slide Note
Embed
Share

A case report explores the use of optical genome mapping (OGM) to unravel a complex KMT2A rearrangement in an AML patient. Traditional cytogenetic analyses identified translocations and rearrangements involving chromosomes 10 and 11, leading to the fusion of genes KMT2A and MLLT10. OGM technique, utilized to analyze ultra-long DNA fragments, provided detailed insights into the structural aberrations at a genome-wide level. This innovative approach offers a novel perspective on characterizing intricate genetic mechanisms in leukemia cases.

  • Optical Genome Mapping
  • AML
  • KMT2A Rearrangement
  • Genetic Analysis
  • Leukemia

Uploaded on Aug 03, 2024 | 4 Views


Download Presentation

Please find below an Image/Link to download the presentation.

The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author. Download presentation by click this link. If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.

E N D

Presentation Transcript


  1. CASE REPORT: the use of optical genome mapping (Bionano) to understand a complex mechanism of a KMT2A rearrangement in an AML case. C line L t 1, Genevi ve Ameye , Pablo Beckers1, Lucienne Michaux , Vincent Bours, Mauricette Jamar1, Jolien De Bie , Barbara Dewaele , Catherine Menten1 1Human genetics, CHU Li ge, Belgium Center for Human Genetics , UZ Leuven, Belgium Catherine Menten and Barbara Dewaele Cytogenetic lab, human genetic, CHU Li ge, Belgium

  2. Introduction : the diagnosis of AML M5 (FAB classification) was established after cytology and cytometry analysis in an eighty-six year old woman with 46% myeloblasts in the bone marrow. A B Content A : standard karyotype Q-banding : 46,XX,t(10;11)(p12;q23) B : specific KMTA FISH (break apart probe, Vysis) Standard karyotype shows a translocation t(10;11)(p12;q23) in seventeen mitoses. KMT2A rearrangement was confirmed by FISH analysis using a gene specific break apart probe. However, the observation of informative metaphases shows that the KMT2A rearrangement is located on the short arm of a derivative chromosome 10. Catherine Menten and Barbara Dewaele Cytogenetic lab, human genetic, CHU Li ge, Belgium 2

  3. Aim: MLLT10 fusion is known to result from an inversion which can occur either before or after the t(10;11) translocation. An RT-PCR Hemavision test would have been informative, but was not possible due to the lack of RNA. Optical genome mapping (OGM) is a new, all in one , technique allowing the genome-wide detailed characterization of most structural rearrangements (balanced or not) . Results : 1. Ultra long DNA fragments (>150kb) extracted from bone marrow labeled then linearised using Saphyr (Bionano Genomics). Then, the pattern was compared with reference genome via OGM technique, showing pseudodiplo d with complex aberrations involving a MLLT10-KMT2A rearrangement. were karyotype Chromosome 10 (right) and 11 (left) ( Bionano Access (Genome build GRCh37/hg19)) after bio- computing analyses using De Novo Assembly (coverage 150x), Rare variant (coverage 300x) and Copy Number Analysis (coverage 300x) pipelines . Catherine Menten and Barbara Dewaele Cytogenetic lab, human genetic, CHU Li ge, Belgium 3

  4. Results : 2. After independent analyses, we observed two inversions inside the long arm of one chromosome 11 and two translocations between the short arm of one chromosome 10 and the long arm of chromosome 11 which ultimately lead to the fusion of the genes KMT2A and MLLT10. A C 10p12.31 11q14.2 TMEM135 MLLT10 KMT2A KMT2A 11q23.3 11q23.3 11q13.4 FAM168A B D 10p12.31 PLEKHB1RAB6A MLLT10 PLEKHB1 RAB6A FAM168A TMEM135 11q13.4 11q14.2 C : inv(11)(q14.2q23.3)(86854533_118364657inv) D : inv(11)(q13.4q14.2)(73340798_86847507inv) A : t(10;11)(p12.31;q23.3)(21912195;118349783) B : t(10;11)(p12.31;q13.4)(21861988;73345254) Catherine Menten and Barbara Dewaele Cytogenetic lab, human genetic, CHU Li ge, Belgium 4

  5. Conclusion : OGM technique allowed us to observe a KMT2A- MLLT10 fusion resulting from several anomalies involving chromosome 10 and 11: ogm\[GRCh37\] t(10;11)(p12.31;q13.4)(21861988;73345254), [MLLT10-PLEKHB1] t(10;11)(p12.31;q23.3)(21912195;118349783), [MLLT10-KMT2A] inv(11)(q13.4q14.2)(73340798_86847507inv), inv(11)(q14.2q23.3)(86854533_118364657inv) We conclude that the analysis of this AML case nicely illustrates the value of OGM to resolve complex aberrations using only one assay. Catherine Menten and Barbara Dewaele Cytogenetic lab, human genetic, CHU Li ge, Belgium 5

Related


More Related Content

giItT1WQy@!-/#giItT1WQy@!-/#giItT1WQy@!-/#giItT1WQy@!-/#giItT1WQy@!-/#giItT1WQy@!-/#